This association bears great therapeutical potential, as allosteric activators of glucocerebrosidase restore lysosomal function [61] and have recently been proven safe in humans [62], underscoring the possibility of extending their application to management of AD in APOE4 carriers. Here, APOE is linked to Alzheimer disease.